Norfloxacin Ophthalmic Solution 0.3% (Noflo® / ノフロ点眼液0.3%)

JPY ¥7,200

Japanese broad-spectrum antibacterial ophthalmic agent (Norfloxacin 0.3%). Ophthalmic solution for bacterial eye infections and perioperative antiseptic therapy. 5mL x 10 bottles [plastic bottle]. Mfd. by Nichi-Iko Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥6,624
10 - 19 12% JPY ¥6,336
20 + 18% JPY ¥5,904
SKU: NOF-03-OPH Category:

Description

Product Overview / 商品概要

Norfloxacin Ophthalmic Solution 0.3% (ノフロ点眼液0.3%)
Generic: Norfloxacin / ノルフロキサシン
Therapeutic Category: Broad-spectrum antibacterial ophthalmic agent / 広範囲抗菌点眼剤
Manufactured by: Nichi-Iko Pharmaceutical Co., Ltd. / 日医工株式会社

Composition & Specification / 組成・規格

Active Ingredient: Norfloxacin 3.0mg/mL per 1 vial (5mL) / 1瓶(5mL)中 ノルフロキサシン 3.0mg/mL
Additives: Sodium acetate hydrate, Sodium edetate hydrate, Sodium chloride, Hydrochloric acid / 酢酸ナトリウム水和物、エデト酸ナトリウム水和物、塩化ナトリウム、塩酸
Appearance: Sterile aqueous ophthalmic solution, colorless and clear, pH 5.0–5.6, osmolarity ratio approximately 1 (relative to physiological saline)
外観: 無菌水性点眼剤、無色澄明、pH 5.0~5.6、浸透圧比 約1(生理食塩液に対する比)

Indications / 効能効果

EN: Susceptible organisms: Staphylococcus spp., Streptococcus spp., Streptococcus pneumoniae, Enterococcus spp., Micrococcus spp., Moraxella spp., Corynebacterium spp., Bacillus spp., Klebsiella spp., Enterobacter spp., Serratia spp., Proteus spp., Haemophilus influenzae, Haemophilus aegyptius (Koch-Weeks bacillus), Pseudomonas spp., Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas (Xanthomonas) maltophilia, Acinetobacter spp., Flavobacterium spp., Alcaligenes spp.
Indications: Blepharitis, dacryocystitis, hordeolum, conjunctivitis, meibomianitis, keratitis (including corneal ulcer), perioperative antiseptic therapy in ophthalmology
JA: 〈適応菌種〉本剤に感性のブドウ球菌属、レンサ球菌属、肺炎球菌、腸球菌属、ミクロコッカス属、モラクセラ属、コリネバクテリウム属、バシラス属、クレブシエラ属、エンテロバクター属、セラチア属、プロテウス属、インフルエンザ菌、ヘモフィルス・エジプチウス(コッホ・ウィークス菌)、シュードモナス属、緑膿菌、バークホルデリア・セパシア、ステノトロホモナス(ザントモナス)・マルトフィリア、アシネトバクター属、フラボバクテリウム属、アルカリゲネス属
〈適応症〉眼瞼炎、涙嚢炎、麦粒腫、結膜炎、瞼板腺炎、角膜炎(角膜潰瘍を含む)、眼科周術期の無菌化療法

Dosage and Administration / 用法用量

EN: Usually, instill 1 drop at a time, 3 times daily. The dose may be adjusted according to symptoms.
JA: 通常、1回1滴、1日3回点眼する。なお、症状により適宜増減する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to norfloxacin or quinolone antibacterial agents
JA: ノルフロキサシン又はキノロン系合成抗菌剤に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 21900AMX00105000
Sales Started: August 1989 / 1989年8月
Classification Code: 871319
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 5mL x 10 bottles [plastic bottle] / 5mL×10本[プラスチックボトル]
Other Available Packages (by special order): 5mL x 10 bottles [plastic bottle]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Norfloxacin Ophthalmic Solution 0.3% (Noflo® / ノフロ点眼液0.3%)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Norfloxacin Ophthalmic Solution 0.3% (Noflo®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.